VIR - Vir Biotechnology, Inc.
9.1
-0.460 -5.055%
Share volume: 2,457,741
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$9.56
-0.46
-0.05%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-26-2025 | 05-07-2025 | 11-05-2025 | 02-23-2026 | |
| Total revenue | 12.374 M | 3.032 M | 0.000 | 64.310 M | |
| Cost of revenue | 684.000 K | 0.000 | 0.000 | 15.000 K | |
| Gross profit | 11.690 M | 3.032 M | 0.000 | 64.295 M | |
| -74.06% | -100.00% | inf% | |||
| Operating expenses | 132.832 M | 142.589 M | 173.694 M | 111.965 M | |
| Selling general and admin | 26.749 M | 23.944 M | 22.231 M | 23.616 M | |
| Research and development | 106.083 M | 118.645 M | 151.463 M | 88.349 M | |
| Total expenses | 128.840 M | 142.579 M | 173.694 M | 111.965 M | |
| 10.66% | 21.82% | -35.54% | |||
| Operating income | -117.150 M | -139.547 M | -173.443 M | -47.921 M | |
| Ebit | -118.828 M | -133.237 M | -172.336 M | -50.862 M | |
| Pretax income | -104.675 M | -120.949 M | -162.973 M | -43.060 M | |
| 15.55% | 34.75% | -73.58% | |||
| Income tax | -86.000 K | 16.000 K | 168.000 K | -137.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -104.589 M | -120.965 M | -163.141 M | -42.923 M | |
| -15.66% | -34.87% | 73.69% |